Trial Profile
Efficacy of rosuvastatin for the treatment of Non-alcoholic fatty liver disease with hyperlipidaemia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2013
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia; Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 06 Jun 2012 New trial record